Claypoole Robert E bought BVS
March 14, 2025 · Form 4 insider transaction
Claypoole Robert E bought 134,000 shares of Bioventus Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 368 days after the transaction.
Direction
Acquired (buy-side)
Shares
134,000
Price
$0.00
Total value
N/A
InsiderClaypoole Robert E
Role—
CompanyBioventus Inc. (BVS)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 14, 2025
Filing dateMarch 17, 2026
Shares owned after134,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.; The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of March 15, 2025, in each case subject to the Reporting Person continuing in service through the applicable vesting date.